179 related articles for article (PubMed ID: 25510089)
1. [Comparison of the effectiveness of omeprazole and pantoprazole treatment of gastroesophageal reflux disease in patients with asthma].
Popadynets' IR
Lik Sprava; 2013 Sep; (6):47-53. PubMed ID: 25510089
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of gastro-esophageal reflux disease in patients with difficult to control asthma and effect of proton pump inhibitor therapy on asthma symptoms, reflux symptoms, pulmonary function and requirement for asthma medications.
Sandur V; Murugesh M; Banait V; Rathi PM; Bhatia SJ; Joshi JM; Kate A
J Postgrad Med; 2014; 60(3):282-6. PubMed ID: 25121368
[TBL] [Abstract][Full Text] [Related]
3. Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
Calabrese C; Liguori G; Gabusi V; Gionchetti P; Rizzello F; Straforini G; Brugnera R; Di Febo G
Aliment Pharmacol Ther; 2008 Jul; 28(2):250-5. PubMed ID: 18485128
[TBL] [Abstract][Full Text] [Related]
4. [The influence of gastroesophageal reflux on the course and therapy of bronchial asthma].
Samoliński B
Pol Merkur Lekarski; 2006 Oct; 21(124):307-9. PubMed ID: 17205765
[TBL] [Abstract][Full Text] [Related]
5. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.
Howden CW; Ballard ED; Koch FK; Gautille TC; Bagin RG
J Clin Gastroenterol; 2009 Apr; 43(4):323-6. PubMed ID: 18758373
[TBL] [Abstract][Full Text] [Related]
6. Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy.
Calabrese C; Fabbri A; Areni A; Scialpi C; Zahlane D; Di Febo G
World J Gastroenterol; 2005 Dec; 11(48):7657-60. PubMed ID: 16437694
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, safety, and tolerability of pantoprazole magnesium in the treatment of reflux symptoms in patients with gastroesophageal reflux disease (GERD): a prospective, multicenter, post-marketing observational study.
Remes-Troche JM; Sobrino-Cossío S; Soto-Pérez JC; Teramoto-Matsubara O; Morales-Arámbula M; Orozco-Gamiz A; Tamayo de la Cuesta JL; Mateos G
Clin Drug Investig; 2014 Feb; 34(2):83-93. PubMed ID: 24347282
[TBL] [Abstract][Full Text] [Related]
8. The effect of proton pump inhibitors on the CYP2C19 enzyme activity evaluated by the pantoprazole-
Modak AS; Klyarytska I; Kriviy V; Tsapyak T; Rabotyagova Y
J Breath Res; 2016 Dec; 10(4):046017. PubMed ID: 27991432
[TBL] [Abstract][Full Text] [Related]
9. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.
Harding SM; Richter JE; Guzzo MR; Schan CA; Alexander RW; Bradley LA
Am J Med; 1996 Apr; 100(4):395-405. PubMed ID: 8610725
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of actual costs in long-term therapy of reflux disease. Use of pantoprazole counts].
MMW Fortschr Med; 2008 Oct; 150(40):52-3. PubMed ID: 18990887
[No Abstract] [Full Text] [Related]
11. Treating silent reflux disease does not improve poorly controlled asthma.
Riscili BP; Parsons JP; Mastronarde JG
Cleve Clin J Med; 2010 Mar; 77(3):155-60. PubMed ID: 20200165
[TBL] [Abstract][Full Text] [Related]
12. Effect of omeprazole and domperidone on adult asthmatics with gastroesophageal reflux.
Sharma B; Sharma M; Daga MK; Sachdev GK; Bondi E
World J Gastroenterol; 2007 Mar; 13(11):1706-10. PubMed ID: 17461474
[TBL] [Abstract][Full Text] [Related]
13. Gastroesophageal reflux disease in bronchial asthma and the response to omeprazole.
Gopal B; Singhal P; Gaur SN
Asian Pac J Allergy Immunol; 2005 Mar; 23(1):29-34. PubMed ID: 15997872
[TBL] [Abstract][Full Text] [Related]
14. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
Miner P; Katz PO; Chen Y; Sostek M
Am J Gastroenterol; 2003 Dec; 98(12):2616-20. PubMed ID: 14687806
[TBL] [Abstract][Full Text] [Related]
15. Impact of pantoprazole on duodeno-gastro-esophageal reflux (DGER).
Kunsch S; Neesse A; Linhart T; Steinkamp M; Fensterer H; Adler G; Gress TM; Ellenrieder V
Z Gastroenterol; 2009 Mar; 47(3):277-82. PubMed ID: 19280541
[TBL] [Abstract][Full Text] [Related]
16. Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial.
Madan K; Ahuja V; Kashyap PC; Sharma MP
Dis Esophagus; 2004; 17(4):274-8. PubMed ID: 15569362
[TBL] [Abstract][Full Text] [Related]
17. [Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors].
Ter Arkh; 2012; 84(2):16-21. PubMed ID: 22715656
[TBL] [Abstract][Full Text] [Related]
18. The role of proton-pump inhibitor therapy in patients with gastroesophageal reflux disease and difficult-to-control asthma.
Goh KL; Wong CH
Expert Opin Pharmacother; 2006 Oct; 7(15):2015-7. PubMed ID: 17020428
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pantoprazol treatment response of patients with asthma and gastroesophageal reflux: a randomized prospective double-blind placebo-controlled study.
dos Santos LH; Ribeiro IO; Sánchez PG; Hetzel JL; Felicetti JC; Cardoso PF
J Bras Pneumol; 2007; 33(2):119-27. PubMed ID: 17724529
[TBL] [Abstract][Full Text] [Related]
20. [Proton pump inhibition: more than only reflux therapy].
MMW Fortschr Med; 2008 Nov; 150(46):48-9. PubMed ID: 19133361
[No Abstract] [Full Text] [Related]
[Next] [New Search]
